Characterization of the anti-pathogenic, genomic and phenotypic properties of a Lacticaseibacillus rhamnosus VHProbi M14 isolate.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 20 02 2023
accepted: 24 04 2023
medline: 17 5 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: epublish

Résumé

A strain of lactic acid bacteria from cheese was isolated, that showed strong growth inhibitory effects on Streptococcus mutans. The API 50CH system and 16S rDNA sequencing verified that this was a novel strain, and was named Lacticaseibacillus rhamnosus VHProbi M14. The strain inhibited the growth of S. mutans and Fusobacterium nucleatum under mixed culture conditions, coaggregated with S. mutans and F. nucleatum, and reduced the adhesion of S. mutans and F. nucleatum on cultured human primary gingival epithelial (HPGE) cells. The pH, peroxidase and protease sensitivity testing found antibacterial substances of protein- and peptide-like structures in addition to organic acids. The antimicrobial substances were sensitive to hydrolysis with trypsin, papain and pineapple protease and were inactived at temperatures above 100°C. Ammonium sulphate-precipitated proteins from the M14 strain retained the ability to inhibit the growth of S. mutans and F. nucleatum. The M14 strain contained 23 bacteriocin-related genes encoding for metabolites, belonging to class II bacteriocins. The M14 strain also showed inhibitory effects on 8 other pathogenic strains (A. actinomycetemcomitans, C. albicans, E. coli, G. vaginalis, P. acnes, P. gingivalis, S. aureus, S. enteritids), and thus has a broad spectrum of bacterial inhibition. This new isolate has been identified as having potential to be used as a probiotic bacterium in clinical applications.

Identifiants

pubmed: 37186610
doi: 10.1371/journal.pone.0285480
pii: PONE-D-23-04919
pmc: PMC10184941
doi:

Substances chimiques

Bacteriocins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0285480

Informations de copyright

Copyright: © 2023 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Infect Immun. 1979 Jun;24(3):742-52
pubmed: 468376
Microb Cell Fact. 2021 Mar 23;20(1):75
pubmed: 33757506
Food Sci Nutr. 2020 May 12;8(6):2854-2863
pubmed: 32566203
Front Microbiol. 2021 Jun 01;12:664604
pubmed: 34140939
Gigascience. 2012 Dec 27;1(1):18
pubmed: 23587118
Acta Odontol Scand. 2009;67(5):284-8
pubmed: 19479452
Bol Med Hosp Infant Mex. 1962 Mar-Apr;19:225-37
pubmed: 14490163
Int J Food Microbiol. 1999 Sep 15;50(1-2):1-17
pubmed: 10488839
J Clin Periodontol. 2009 Jun;36(6):506-13
pubmed: 19453574
J Infect Dis. 1992 Jun;165(6):1142-4
pubmed: 1316413
Front Microbiol. 2020 Apr 30;11:774
pubmed: 32425911
Oral Microbiol Immunol. 2006 Apr;21(2):79-83
pubmed: 16476016
J Appl Microbiol. 2001 Feb;90(2):172-9
pubmed: 11168719
Oral Microbiol Immunol. 2005 Dec;20(6):354-61
pubmed: 16238595
J Am Dent Assoc. 1995 Oct;126(10):1384-93
pubmed: 7594010
Eur J Oral Sci. 2007 Aug;115(4):308-14
pubmed: 17697171
Caries Res. 2001 Nov-Dec;35(6):412-20
pubmed: 11799281
Oral Microbiol Immunol. 1990 Jun;5(3):137-42
pubmed: 2080068
Biology (Basel). 2022 Sep 19;11(9):
pubmed: 36138851
J Bacteriol. 1991 Jan;173(2):697-703
pubmed: 1987160
Oral Dis. 2007 Sep;13(5):443-51
pubmed: 17714346
BMC Microbiol. 2016 Aug 18;16(1):188
pubmed: 27538539
Int J Food Microbiol. 2004 Sep 1;95(2):219-23
pubmed: 15282133
Lett Appl Microbiol. 1996 Jun;22(6):420-4
pubmed: 8695066
J Med Microbiol. 2008 Dec;57(Pt 12):1560-1568
pubmed: 19018030
J Clin Microbiol. 1981 Mar;13(3):594-5
pubmed: 7016904
J Microbiol Biotechnol. 2015 Dec 28;25(12):2160-8
pubmed: 26428734
Cureus. 2020 Oct 5;12(10):e10812
pubmed: 33173621
Microb Pathog. 2022 Dec;173(Pt A):105857
pubmed: 36397614
Curr Pharm Biotechnol. 2009 Jan;10(1):19-37
pubmed: 19149588
Clin Microbiol Rev. 2016 Apr;29(2):223-38
pubmed: 26864580
Adv Dent Res. 1994 Jul;8(2):263-71
pubmed: 7865085
Adv Appl Microbiol. 2016;97:171-210
pubmed: 27926431
Annu Rev Microbiol. 2000;54:413-37
pubmed: 11018133
Oral Dis. 2000 Jul;6(4):227-33
pubmed: 10918560
J Obstet Gynaecol Res. 2022 Mar;48(3):857-865
pubmed: 34970814
Arch Microbiol. 2014 Aug;196(8):601-9
pubmed: 24919536
J Appl Microbiol. 1997 Jul;83(1):127-32
pubmed: 9246779
Front Biosci. 2004 May 01;9:1267-77
pubmed: 14977543
Medicina (Kaunas). 2022 May 28;58(6):
pubmed: 35743986
J Appl Microbiol. 1998 Jul;85(1):88-94
pubmed: 9721659
Nucleic Acids Res. 2017 Jul 3;45(W1):W36-W41
pubmed: 28460038
J Agric Food Chem. 2018 Mar 7;66(9):2071-2082
pubmed: 29464948
FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):181-91
pubmed: 14522453
J Gen Microbiol. 1987 Nov;133(11):3207-17
pubmed: 2895798
J Appl Bacteriol. 1996 Dec;81(6):669-77
pubmed: 8972094
J Clin Microbiol. 1989 Feb;27(2):251-6
pubmed: 2915019
Appl Environ Microbiol. 1995 Mar;61(3):1061-7
pubmed: 7793908
Nucleic Acids Res. 2014 Jan;42(Database issue):D490-5
pubmed: 24270786

Auteurs

Jingyan Zhang (J)

Qingdao Vland Biotech Inc, Nutrition & Health Technology Center, Qingdao, China.

Kailing Li (K)

Qingdao Vland Biotech Inc, Nutrition & Health Technology Center, Qingdao, China.

Xinping Bu (X)

Qingdao Vland Biotech Inc, Nutrition & Health Technology Center, Qingdao, China.

Shumin Cheng (S)

Qingdao Vland Biotech Inc, Nutrition & Health Technology Center, Qingdao, China.

Zhi Duan (Z)

Qingdao Vland Biotech Inc, Nutrition & Health Technology Center, Qingdao, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH